Ownership history in JACOBS & CO/CA · 87 quarters on record
This page tracks every 13F SEC filing in which JACOBS & CO/CA reported a position in AmgenIncorporated (AMGN). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | REDUCED | 43,579 | -1,480 | -3.3% | 1.35% | $14.3M | $325.06 |
| 2025 Q3 | ADDED | 45,059 | +1,078 | +2.5% | 1.22% | $12.7M | $278.27 |
| 2025 Q2 | ADDED | 43,981 | +62 | +0.1% | 1.22% | $12.3M | $273.11 |
| 2025 Q1 | REDUCED | 43,919 | -237 | -0.5% | 1.46% | $13.7M | $302.07 |
| 2024 Q4 | ADDED | 44,156 | +78 | +0.2% | 1.17% | $11.5M | $250.69 |
| 2024 Q3 | REDUCED | 44,078 | -812 | -1.8% | 1.42% | $14.2M | $307.45 |
| 2024 Q2 | REDUCED | 44,890 | -363 | -0.8% | 1.47% | $14.0M | $296.07 |
| 2024 Q1 | REDUCED | 45,253 | -1 | -0.0% | 1.36% | $12.9M | $267.52 |
| 2023 Q4 | REDUCED | 45,254 | -739 | -1.6% | 1.48% | $13.0M | $268.90 |
| 2023 Q3 | REDUCED | 45,993 | -894 | -1.9% | 1.54% | $12.4M | $248.96 |
As of 2025 Q4 — sorted by position size